We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISV
8026
CALL
Fiserv Inc
FISV
$28.9B
$19K ﹤0.01%
600
-200
-25% -$6.32K
HURC icon
8027
Hurco Companies Inc
HURC
$135M
$19K ﹤0.01%
500
+461
+1,182% +$15.3K
IFF icon
8028
PUT
International Flavors & Fragrances
IFF
$20.2B
$19K ﹤0.01%
200
-200
-50% -$20.2K
KN icon
8029
CALL
Knowles
KN
$3.07B
$19K ﹤0.01%
+700
New +$21.4K
LQDT icon
8030
CALL
Liquidity Services
LQDT
$1.23B
$19K ﹤0.01%
1,400
+1,100
+367% +$15.8K
MAG
8031
CALL
DELISTED
MAG Silver
MAG
$19K ﹤0.01%
2,500
-4,800
-66% -$42.3K
MGYR icon
8032
Magyar Bancorp
MGYR
$123M
$19K ﹤0.01%
2,778
+940
+51% +$6.24K
MTH icon
8033
Meritage Homes
MTH
$4.89B
$19K ﹤0.01%
1,092
-1,988
-65% -$39.9K
NOTV
8034
DELISTED
Inotiv
NOTV
$19K ﹤0.01%
8,438
+6,228
+282% +$14.5K
NVO
8035
PUT
Novo Nordisk
NVO
$225B
$19K ﹤0.01%
800
-21,000
-96% -$483K
OCUL icon
8036
Ocular Therapeutix
OCUL
$1.85B
$19K ﹤0.01%
+1,272
New +$18.8K
PETS icon
8037
CALL
PetMed Express
PETS
$43M
$19K ﹤0.01%
1,400
-2,400
-63% -$33.4K
PODD icon
8038
Insulet
PODD
$11.6B
$19K ﹤0.01%
497
-625
-56% -$22.8K
RTH icon
8039
PUT
VanEck Retail ETF
RTH
$254M
$19K ﹤0.01%
+300
New +$18.3K
SAR icon
8040
Saratoga Investment
SAR
$314M
$19K ﹤0.01%
1,170
-207
-15% -$3.3K
SEED icon
8041
Origin Agritech
SEED
$11.9M
$19K ﹤0.01%
887
-456
-34% -$9.62K
UGE icon
8042
ProShares Ultra Consumer Staples
UGE
$12.8M
$19K ﹤0.01%
+2,664
New +$19.2K
WTRG icon
8043
CALL
Essential Utilities
WTRG
$11.5B
$19K ﹤0.01%
800
-500
-38% -$12.2K
TVRD
8044
Tvardi Therapeutics
TVRD
$22.9M
$19K ﹤0.01%
63
-164
-72% -$67.3K
YTEN
8045
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
MTBL
8046
CALL
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$19K ﹤0.01%
3,733
AMRS
8047
DELISTED
Amyris Inc.
AMRS
$19K ﹤0.01%
338
+271
+404% +$16K
GER
8048
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$19K ﹤0.01%
+103
New +$18.6K
DISCK
8049
CALL
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$19K ﹤0.01%
+500
New +$20.2K
LDL
8050
PUT
DELISTED
Lydall, Inc.
LDL
$19K ﹤0.01%
700
+600
+600% +$16.6K

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.